Zhanxue Xu

5PUBLICATIONS
26CO-AUTHORS
Innate immunityGenetically modified horticulture plantsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 01, 2024
Reactive Oxygen Species Responsive Multifunctional Fusion Extracellular Nanovesicles: Prospective Treatments for Acute Heart Transplant Rejection.

Xingyu Lu, Zhanxue Xu, Fan Shu

|Oct 20, 2023
Plant exosomes fused with engineered mesenchymal stem cell-derived nanovesicles for synergistic therapy of autoimmune skin disorders.

Rufan Huang, Bo Jia, Dandan Su

|Jun 24, 2022
PD-1 Cellular Nanovesicles Carrying Gemcitabine to Inhibit the Proliferation of Triple Negative Breast Cancer Cell.

Hualian Zha, Zhanxue Xu, Xichao Xu

|Dec 28, 2020
PD-L1 cellular nanovesicles carrying rapamycin inhibit alloimmune responses in transplantation.

Min Yang, Zhanxue Xu, Hailan Yan

|Jun 10, 2020
Engineering Programmed Death Ligand-1/Cytotoxic T-Lymphocyte-Associated Antigen-4 Dual-Targeting Nanovesicles for Immunosuppressive Therapy in Transplantation.

Zhanxue Xu, Hsiang-I Tsai, Youmei Xiao

Pageof 1

Frequent Collaborators

5 joint publications

Hongbo Chen

3 joint publications

Dandan Su

3 joint publications

Fang Cheng

2 joint publications

Hsiang-I Tsai